Together they have invented a handheld device called an oscillation spirometer that will give doctors a new sensitive tool to measure airway function. AV整氈窒 and SCIREQ are forming a new Halifax-based company, Thoracic Medical Systems Inc. (Thorasys), to develop this and other medical devices for market.
This breakthrough device will aid doctors both in diagnosing asthma and in monitoring the effectiveness of asthma treatment. It will be particularly helpful in diagnosing asthma in children an important advance as asthma most frequently emerges in childhood.
Its very difficult for children to perform traditional spirometry tests, which require them to blow as much air out of their lungs as they can in one second, notes lead researcher Dr. Geoffrey Maksym, an associate professor in AV整氈窒 School of Biomedical Engineering. Our device is easier for people to use, because it measures airway function while they are breathing normally.
|
Maksym has been working on the methods and technology behind the oscillation spirometer for more than four years, in collaboration with SCIREQ, his graduate students and Dr. Paul Hernandez, a QEII respirologist and associate professor at AV整氈窒 Medical School. The Natural Sciences and Engineering Council of Canada (NSERC) has funded his work from the start, investing $450,000 so far. Springboard Atlantic, the Nova Scotia Lung Association and AV整氈窒s Industry Liaison and Innovation Office have provided additional funds and support.
AV整氈窒s Industry Liaison and Innovation Office (ILI) plays a central role in the project, evaluating and protecting intellectual property, assisting with funding proposals, and guiding the project through the commercialization process.
This is a prime example of research that matters, says Dr. Ronald Layden, executive director of the ILI. It combines all the elements we like to see: high-calibre research, great commercial potential, and a means of meeting an important medical need. On top of this the new firm, Thorasys, will create high-tech jobs in Halifax and strengthen the regions fledgling biomedical devices industry.
Specialists at the IWK Health Centre and QEII Health Sciences Centre in Halifax, as well as the Mayo Clinic in Rochester, Minnesota, will begin using the oscillation spirometer this year. Their feedback will provide valuable input to Thorasys as the company moves the device to market.
Maksym says it really all began in the 1990s, when he and Dr. Thomas Schuessler were graduate students together at McGill Universitys Meakins-Christie Institute, a world-renowned centre for lung research. Maksym went on to become a professor, while Schuessler formed SCIREQ. The two stayed in contact and began working together on this project in 2004. Six students in Maksyms lab have since worked with SCIREQ to develop the oscillation spirometer prototypes. Schuessler is taking on the role of president of Thorasys, while Maksym will be the companys scientific advisor.
SEE VIDEO: Geoffrey Maksym demonstrates the oscillation spirometer and explains its benefits.
READ: by Canadian Press